Abiomed Company Profile (NASDAQ:ABMD)

About Abiomed

Abiomed logoAbiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company's products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ABMD
  • CUSIP: 00365410
Key Metrics:
  • Previous Close: $128.42
  • 50 Day Moving Average: $121.83
  • 200 Day Moving Average: $107.68
  • 52-Week Range: $67.81 - $131.16
  • Trailing P/E Ratio: 136.72
  • Foreward P/E Ratio: 76.09
  • P/E Growth: 3.99
  • Market Cap: $5.50B
  • Outstanding Shares: 42,811,000
  • Beta: 0.89
Profitability:
  • Net Margins: 11.75%
  • Return on Equity: 11.86%
  • Return on Assets: 10.43%
Debt:
  • Current Ratio: 6.95%
  • Quick Ratio: 6.28%
Additional Links:
Companies Related to Abiomed:

Analyst Ratings

Consensus Ratings for Abiomed (NASDAQ:ABMD) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $116.67 (9.27% downside)

Analysts' Ratings History for Abiomed (NASDAQ:ABMD)
Show:
DateFirmActionRatingPrice TargetDetails
9/28/2016Leerink SwannReiterated RatingOutperform$125.00View Rating Details
8/9/2016Jefferies GroupBoost Price TargetBuy$130.00 -> $145.00View Rating Details
4/10/2016Benchmark Co.Reiterated RatingBuy$145.00View Rating Details
2/5/2016Piper Jaffray Cos.Reiterated RatingHold$75.00 -> $90.00View Rating Details
2/5/2016BTIG ResearchReiterated RatingBuy$110.00View Rating Details
10/30/2015Raymond James Financial Inc.UpgradeMarket Perform -> Outperform$85.00View Rating Details
10/29/2015Sterne Agee CRTReiterated RatingBuyView Rating Details
8/17/2015CRT CapitalInitiated CoverageBuyView Rating Details
8/14/2015StephensReiterated RatingOverweight$103.00 -> $128.00View Rating Details
8/5/2015Northland SecuritiesBoost Price TargetMarket Perform$60.00 -> $80.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Abiomed (NASDAQ:ABMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
7/28/2016Q117$0.23$0.29$97.23 million$103.00 millionViewListenView Earnings Details
5/3/2016Q416$0.19$0.24$90.52 million$94.00 millionViewN/AView Earnings Details
2/4/2016Q316$0.15$0.23$80.04 million$85.80 millionViewListenView Earnings Details
10/29/2015Q2$0.13$0.17$74.56 million$76.30 millionViewListenView Earnings Details
8/4/2015Q116$0.08$0.20$66.27 million$73.40 millionViewN/AView Earnings Details
5/5/2015Q415$0.12$0.28$62.55 million$67.60 millionViewN/AView Earnings Details
1/28/2015Q315$0.04$0.30$53.20 million$62.00 millionViewN/AView Earnings Details
10/30/2014Q215$0.02$0.03$48.80 million$51.80 millionViewN/AView Earnings Details
7/31/2014Q115$0.01($0.04)$297.10 million$48.80 millionViewN/AView Earnings Details
5/1/2014Q414$0.08$0.09$50.93 million$50.40 millionViewN/AView Earnings Details
1/31/2014Q314$0.05$0.11$46.00 million$46.20 millionViewN/AView Earnings Details
11/6/2013Q214$0.03$0.03$43.75 million$44.30 millionViewN/AView Earnings Details
8/1/2013Q1 2014$0.06($0.04)$42.93 million$42.70 millionViewN/AView Earnings Details
5/2/2013Q4 2013$0.08$0.09$41.87 million$43.70 millionViewN/AView Earnings Details
2/6/2013Q3 2013$0.07$0.07$38.04 million$38.30 millionViewN/AView Earnings Details
11/1/2012Q213$0.05$0.20$37.47 million$37.40 millionViewN/AView Earnings Details
8/2/2012$0.10$0.16ViewN/AView Earnings Details
5/16/2012$0.07$0.07ViewN/AView Earnings Details
2/3/2012($0.01)$0.07ViewN/AView Earnings Details
11/3/2011($0.09)$0.02ViewN/AView Earnings Details
8/4/2011($0.06)($0.03)ViewN/AView Earnings Details
5/18/2011($0.04)($0.05)ViewN/AView Earnings Details
2/3/2011($0.09)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Abiomed (NASDAQ:ABMD)
Current Year EPS Consensus Estimate: $1.14 EPS
Next Year EPS Consensus Estimate: $1.69 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.12$0.20$0.16
Q2 20163$0.22$0.25$0.23
Q3 20164$0.19$0.28$0.25
Q4 20164$0.25$0.34$0.29
Q1 20176$0.20$0.29$0.24
Q2 20173$0.22$0.24$0.23
Q3 20173$0.29$0.31$0.30
Q4 20172$0.32$0.33$0.33
Q1 20182$0.37$0.38$0.38
Q2 20182$0.29$0.34$0.32
Q3 20182$0.39$0.45$0.42
Q4 20182$0.42$0.51$0.47
Q1 20191$0.41$0.41$0.41
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Abiomed (NASDAQ:ABMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Abiomed (NASDAQ:ABMD)
Insider Ownership Percentage: 10.00%
Institutional Ownership Percentage: 93.65%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Michael R MinogueCEOSell28,039$127.07$3,562,915.73View SEC Filing  
9/21/2016Michael R MinogueCEOSell5,034$127.07$639,670.38View SEC Filing  
9/19/2016Michael R MinogueCEOSell58,710$127.00$7,456,170.00View SEC Filing  
8/15/2016Dorothy E PuhyDirectorSell5,160$123.94$639,530.40View SEC Filing  
8/10/2016Dorothy E PuhyDirectorSell3,900$122.31$477,009.00View SEC Filing  
8/8/2016Michael G HowleyVPSell17,853$119.20$2,128,077.60View SEC Filing  
8/1/2016Henri A TermeerDirectorSell25,866$118.70$3,070,294.20View SEC Filing  
6/29/2016Michael G HowleyVPSell10,000$106.58$1,065,800.00View SEC Filing  
6/7/2016Andrew J GreenfieldVPSell9,000$104.16$937,440.00View SEC Filing  
5/23/2016David M WeberCOOSell4,342$96.97$421,043.74View SEC Filing  
5/16/2016David M WeberCOOSell5,604$94.56$529,914.24View SEC Filing  
5/6/2016David M WeberCOOSell2,145$93.82$201,243.90View SEC Filing  
5/5/2016David M WeberCOOSell52,000$95.27$4,954,040.00View SEC Filing  
5/5/2016Paul ThomasDirectorSell7,500$95.14$713,550.00View SEC Filing  
4/18/2016Andrew J GreenfieldVPSell10,000$99.10$991,000.00View SEC Filing  
4/13/2016Michael G HowleyVPSell9,800$98.64$966,672.00View SEC Filing  
4/8/2016Michael G HowleyVPSell200$98.80$19,760.00View SEC Filing  
4/1/2016Dorothy E PuhyDirectorSell10,000$95.02$950,200.00View SEC Filing  
3/31/2016Andrew J GreenfieldVPSell15,000$94.11$1,411,650.00View SEC Filing  
3/24/2016David M WeberCOOSell5,235$89.93$470,783.55View SEC Filing  
3/22/2016Andrew J GreenfieldVPSell24,800$89.06$2,208,688.00View SEC Filing  
3/22/2016Dorothy E PuhyDirectorSell10,000$90.30$903,000.00View SEC Filing  
3/21/2016Andrew J GreenfieldVPSell19,572$89.07$1,743,278.04View SEC Filing  
3/10/2016Andrew J GreenfieldVPSell200$89.00$17,800.00View SEC Filing  
3/8/2016David M WeberCOOSell17,521$85.20$1,492,789.20View SEC Filing  
3/8/2016William J BoltSVPSell17,510$85.19$1,491,676.90View SEC Filing  
3/7/2016David M WeberCOOSell8,111$85.21$691,138.31View SEC Filing  
3/7/2016Dorothy E PuhyDirectorSell4,000$85.00$340,000.00View SEC Filing  
3/7/2016William J BoltSVPSell7,987$85.20$680,492.40View SEC Filing  
2/8/2016Dorothy E. PuhyDirectorSell4,000$80.47$321,880.00View SEC Filing  
8/19/2015Michael R. MinogueCEOSell146,800$104.87$15,394,916.00View SEC Filing  
8/17/2015Dorothy E PuhyDirectorSell2,580$103.91$268,087.80View SEC Filing  
8/14/2015Dorothy E PuhyDirectorSell2,580$105.27$271,596.60View SEC Filing  
7/17/2015Michael G HowleyVPSell21,295$70.00$1,490,650.00View SEC Filing  
6/15/2015Andrew J GreenfieldVPSell3,185$65.00$207,025.00View SEC Filing  
5/29/2015Martin P SutterDirectorBuy7,500$60.17$451,275.00View SEC Filing  
5/27/2015David M WeberCOOSell17,968$60.77$1,091,915.36View SEC Filing  
5/12/2015Michael G HowleyVPSell17,353$66.47$1,153,453.91View SEC Filing  
5/7/2015Andrew J GreenfieldVPSell3,500$71.00$248,500.00View SEC Filing  
5/7/2015Robert BowenCFOSell2,372$71.52$169,645.44View SEC Filing  
5/6/2015David M WeberCOOSell1,605$73.72$118,320.60View SEC Filing  
5/6/2015Michael R MinogueCEOSell8,840$73.12$646,380.80View SEC Filing  
5/6/2015William J BoltSVPSell1,750$74.27$129,972.50View SEC Filing  
3/23/2015David M WeberCOOSell3,765$71.08$267,616.20View SEC Filing  
10/31/2014Andrew J GreenfieldVPSell15,000$31.90$478,500.00View SEC Filing  
10/31/2014Michael R MinogueCEOSell164,000$31.14$5,106,960.00View SEC Filing  
7/28/2014Michael R MinogueCEOSell82,383$26.30$2,166,672.90View SEC Filing  
5/27/2014Andrew J GreenfieldVPSell7,026$21.10$148,248.60View SEC Filing  
5/27/2014David M WeberCOOSell10,172$21.11$214,730.92View SEC Filing  
5/27/2014Michael R MinogueCEOSell90,001$21.19$1,907,121.19View SEC Filing  
5/27/2014Robert BowenCFOSell6,820$21.11$143,970.20View SEC Filing  
5/27/2014William J BoltSVPSell8,029$21.10$169,411.90View SEC Filing  
5/15/2014David WeberCOOSell1,425$20.94$29,839.50View SEC Filing  
5/15/2014Michael HowleyVPSell1,267$20.94$26,530.98View SEC Filing  
5/15/2014Michael MinogueCEOSell4,433$20.94$92,827.02View SEC Filing  
5/15/2014William BoltSVPSell1,110$20.94$23,243.40View SEC Filing  
1/10/2014Robert BowenCFOSell37,500$30.00$1,125,000.00View SEC Filing  
9/3/2013David WeberCOOSell6,500$24.00$156,000.00View SEC Filing  
9/3/2013William BoltSVPSell20,000$24.00$480,000.00View SEC Filing  
8/14/2013William BoltSVPSell21,534$23.35$502,818.90View SEC Filing  
8/13/2013David WeberCOOSell4,400$23.00$101,200.00View SEC Filing  
8/13/2013Michael HowleyVPSell8,400$23.00$193,200.00View SEC Filing  
8/5/2013David WeberCOOSell7,100$22.90$162,590.00View SEC Filing  
8/5/2013Michael HowleyVPSell1,600$23.03$36,848.00View SEC Filing  
8/5/2013Robert BowenCFOSell2,235$22.64$50,600.40View SEC Filing  
8/5/2013W Gerald AustenDirectorSell8,000$22.85$182,800.00View SEC Filing  
8/5/2013William BoltSVPSell20,166$22.70$457,768.20View SEC Filing  
7/31/2013Michael R MinogueCEOSell36,500$25.04$913,960.00View SEC Filing  
7/17/2013Michael G HowleyVPSell10,000$24.45$244,500.00View SEC Filing  
7/15/2013Robert BowenCFOSell40,786$23.50$958,471.00View SEC Filing  
7/11/2013Robert BowenCFOSell1,499$23.50$35,226.50View SEC Filing  
6/4/2013David M WeberCOOSell6,519$21.20$138,202.80View SEC Filing  
6/4/2013Michael G HowleyVPSell3,881$21.20$82,277.20View SEC Filing  
6/4/2013Michael R MinogueCEOSell17,667$21.23$375,070.41View SEC Filing  
6/4/2013Robert BowenCFOSell5,298$21.20$112,317.60View SEC Filing  
6/4/2013William J BoltSVPSell4,967$21.20$105,300.40View SEC Filing  
5/29/2013Michael R MinogueCEOSell58,833$21.83$1,284,324.39View SEC Filing  
5/28/2013David M WeberCOOSell6,018$22.18$133,479.24View SEC Filing  
5/28/2013Michael G HowleyVPSell5,476$22.18$121,457.68View SEC Filing  
5/28/2013Robert BowenCFOSell5,102$22.18$113,162.36View SEC Filing  
5/28/2013William J BoltSVPSell4,629$22.18$102,671.22View SEC Filing  
5/23/2013Andrew J GreenfieldVPSell1,666$21.63$36,035.58View SEC Filing  
5/23/2013Michael R MinogueCEOSell5,666$21.62$122,498.92View SEC Filing  
5/17/2013Robert BowenCFOSell2,715$23.50$63,802.50View SEC Filing  
5/9/2013Michael R MinogueCEOSell20,000$21.00$420,000.00View SEC Filing  
5/7/2013Henri A TermeerDirectorBuy100,000$19.86$1,986,000.00View SEC Filing  
2/25/2013Henri A TermeerDirectorBuy100,000$14.98$1,498,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Abiomed (NASDAQ:ABMD)
DateHeadline
seekingalpha.com logoAbiomed's heart pumps approved in Japan - Seeking Alpha (NASDAQ:ABMD)
seekingalpha.com - September 29 at 8:01 AM
biz.yahoo.com logoABIOMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Exh (NASDAQ:ABMD)
biz.yahoo.com - September 29 at 8:01 AM
seekingalpha.com logoAbiomed's heart pumps approved in Japan (NASDAQ:ABMD)
seekingalpha.com - September 28 at 6:34 PM
4-traders.com logoAbiomed : Impella 2.5and Impella 5.0 Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare (NASDAQ:ABMD)
www.4-traders.com - September 28 at 3:14 PM
finance.yahoo.com logoAbiomed: Heart Pumps Receive Regulatory Approval in Japan (NASDAQ:ABMD)
finance.yahoo.com - September 28 at 3:14 PM
globenewswire.com logoFirst ever percutaneous heart pump approval in Japan (NASDAQ:ABMD)
globenewswire.com - September 27 at 3:16 PM
feeds.reuters.com logoBRIEF-Abiomed Impella 2.5 and Impella 5.0 heart pumps receive regulatory approval from Japan Ministry of Health, Labor & Welfare (NASDAQ:ABMD)
feeds.reuters.com - September 27 at 8:44 AM
investornewswire.com logoAnalysts Expect ABIOMED, Inc. (NASDAQ:ABMD) To Post EPS Of $0.36 - Investor Newswire (NASDAQ:ABMD)
www.investornewswire.com - September 23 at 8:03 AM
News IconAnalyst Views and Growth Review for ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 23 at 8:03 AM
mysmartrend.com logoABIOMED Has Returned 50.7% Since SmarTrend Recommendation (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - September 22 at 3:15 PM
News IconConsensus Take: ABIOMED, Inc. (NASDAQ:ABMD) Earnings & Ratings Watch - Frisco Fastball (NASDAQ:ABMD)
friscofastball.com - September 21 at 3:22 PM
nasdaq.com logoABMD Crosses Above Average Analyst Target - Nasdaq (NASDAQ:ABMD)
www.nasdaq.com - September 20 at 9:01 AM
rttnews.com logoAbiomed Inc. (ABMD) Has Risen To A New High For The Year (NASDAQ:ABMD)
www.rttnews.com - September 19 at 4:05 PM
fidaily.com logoMacquarie Group Ltd Decreases Its Ownership in ABIOMED, Inc. (ABMD) Stock Last Quarter - Finance Daily (NASDAQ:ABMD)
www.fidaily.com - September 15 at 3:15 PM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: ABIOMED, Inc. (NASDAQ:ABMD) - Frisco Fastball (NASDAQ:ABMD)
friscofastball.com - September 15 at 3:15 PM
News IconAnalyst Projections and Growth Recap for ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 15 at 3:15 PM
mysmartrend.com logo40.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - September 15 at 12:07 PM
capitalcube.com logoABIOMED, Inc. – Value Analysis (NASDAQ:ABMD) : September 13, 2016 (NASDAQ:ABMD)
www.capitalcube.com - September 13 at 3:15 PM
capitalcube.com logoABIOMED, Inc. breached its 50 day moving average in a Bearish Manner : ABMD-US : September 12, 2016 (NASDAQ:ABMD)
www.capitalcube.com - September 12 at 3:16 PM
News IconAnalysts Place ABIOMED, Inc. (NASDAQ:ABMD) Under the Lens of the Microscope - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 12 at 8:02 AM
News IconInstitutional Investors Have Decreased Positions in ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 9 at 8:03 AM
News IconABIOMED, Inc. (NASDAQ:ABMD): What is the Sell-side Making of this Stock? - National Daily Press (NASDAQ:ABMD)
www.nationaldailypress.com - September 9 at 8:03 AM
News IconStreet Projections and Growth Recap for ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 8 at 3:15 PM
News IconStock Sliding Down Over the Last Month: ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 8 at 12:14 PM
capitalcube.com logoETF’s with exposure to ABIOMED, Inc. : September 7, 2016 (NASDAQ:ABMD)
www.capitalcube.com - September 7 at 12:12 PM
News IconAnalysts are Chiming in on ABIOMED, Inc. (NASDAQ:ABMD ... - Frisco Fastball (NASDAQ:ABMD)
friscofastball.com - September 6 at 3:13 PM
News IconInstitutions Have Decreased Positions in ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - September 2 at 5:49 AM
mysmartrend.com logo41.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - August 31 at 8:01 AM
News IconStock Up Over the Past Five Trading Days: ABIOMED, Inc. (NASDAQ:ABMD) - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - August 29 at 8:33 PM
News IconWhat Does the Consensus Have to Say About ABIOMED, Inc. (NASDAQ:ABMD)? Crowd & Analysts Chime in - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - August 29 at 3:25 PM
News IconStreet Views and Growth Projections for ABIOMED, Inc. (NASDAQ ... - Post News (NASDAQ:ABMD)
www.kentuckypostnews.com - August 23 at 8:35 PM
mysmartrend.com logoABIOMED Up 43.3% Since SmarTrend Uptrend Call (ABMD) (NASDAQ:ABMD)
www.mysmartrend.com - August 23 at 3:13 PM
capitalcube.com logoETF’s with exposure to ABIOMED, Inc. : August 23, 2016 (NASDAQ:ABMD)
www.capitalcube.com - August 23 at 3:13 PM
biz.yahoo.com logoABIOMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agre (NASDAQ:ABMD)
biz.yahoo.com - August 18 at 8:39 PM
News IconCommit To Buy ABIOMED At $100, Earn 8.3% Annualized Using Options (NASDAQ:ABMD)
www.stockoptionschannel.com - August 17 at 3:16 PM
fidaily.com logoPalo Alto Investors, LLC Lowers Its Holdings in ABIOMED, Inc. (ABMD) - Finance Daily (NASDAQ:ABMD)
www.fidaily.com - August 16 at 8:35 PM
investornewswire.com logoCan ABIOMED, Inc. (NASDAQ:ABMD) Surprise Analysts This Quarter? - Investor Newswire (NASDAQ:ABMD)
www.investornewswire.com - August 16 at 11:52 AM
247wallst.com logoTop Biotechs Are Among Jefferies Growth Stock Favorites (NASDAQ:ABMD)
247wallst.com - August 15 at 10:30 AM
investornewswire.com logoRatings Watch - ABIOMED, Inc. (NASDAQ:ABMD) - Investor Newswire - Investor Newswire (NASDAQ:ABMD)
www.investornewswire.com - August 13 at 11:13 AM
biz.yahoo.com logoABIOMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securit (NASDAQ:ABMD)
biz.yahoo.com - August 11 at 9:06 PM
fidaily.com logoNationwide Fund Advisors Bought A Lot More ABIOMED, Inc. (ABMD) Stock In The Last Quarter - Finance Daily (NASDAQ:ABMD)
www.fidaily.com - August 9 at 3:13 PM
finance.yahoo.com logoABIOMED INC Financials (NASDAQ:ABMD)
finance.yahoo.com - August 9 at 3:13 PM
fidaily.com logoABIOMED, Inc. (ABMD) Investment Up in Latest Report from William Blair Investment Management, LLC - Finance Daily (NASDAQ:ABMD)
www.fidaily.com - August 8 at 8:02 AM
equities.com logoABIOMED Inc. (ABMD) Hits New 52-week High During August 04 Session - Equities.com (NASDAQ:ABMD)
www.equities.com - August 6 at 11:01 AM
capitalcube.com logoETF’s with exposure to ABIOMED, Inc. : August 5, 2016 (NASDAQ:ABMD)
www.capitalcube.com - August 5 at 3:13 PM
fidaily.com logoABIOMED, Inc. (ABMD) Position Up in Latest Report from Brown Capital Management LLC Last Quarter - Finance Daily (NASDAQ:ABMD)
www.fidaily.com - August 4 at 11:47 AM
capitalcube.com logoABIOMED, Inc. :ABMD-US: Earnings Analysis: Q1, 2017 By the Numbers : August 4, 2016 (NASDAQ:ABMD)
www.capitalcube.com - August 4 at 11:47 AM
biz.yahoo.com logoABIOMED INC Files SEC form 10-Q, Quarterly Report (NASDAQ:ABMD)
biz.yahoo.com - August 3 at 3:16 PM
zacks.com logoAbiomed (ABMD) Beats Q1 Earnings & Revenues, Shares Up (NASDAQ:ABMD)
www.zacks.com - August 2 at 8:01 AM
nasdaq.com logoABMD Crosses Above Average Analyst Target (NASDAQ:ABMD)
www.nasdaq.com - August 1 at 3:16 PM

Social

Abiomed (NASDAQ:ABMD) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff